Organization
Imperial College Healthcare NHS Trust
3 clinical trials
9 abstracts
Abstract
Real world experience of trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK.Org: Royal Free London NHS Foundation Trust, The Christie NHS Foundation Trust, Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Guys' and St Thomas' NHS Trust, Belfast Health and Social Care Trust,
Abstract
Emergency treatment for primary intracranial germ cell tumours (PICGCTs).Org: Imperial College Healthcare NHS Trust, London Regional Cancer Center,
Clinical trial
The Development of a Non-typhoidal Salmonella Human Challenge Model: A Safety and Dose Escalation StudyStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
The SABRE Trial: A Single-arm Prospective Study Measuring Safety, Tolerability and Pharmacokinetics of Two SARS-CoV-2 Neutralising Antibodies (C135-LS and C144-LS) Amongst High-risk Special Populations of Vaccine Non-responders.Status: Withdrawn, Estimated PCD: 2022-03-04
Clinical trial
Obeticholic Acid Treatment in Patients With Bile Acid Diarrhoea: an Open-label, Pilot Study of Mechanisms, Safety and Symptom Response.Status: Completed, Estimated PCD: 2014-01-01
Abstract
LANTana trial protocol: An open label, single arm, phase Ib study to evaluate the effect of pre-treatment with ASTX727 (a demethylating agent) followed by lutetium Lu 177 dotatate in patients with progressive, metastatic neuroendocrine neoplasias (NENs).Org: Imperial College London, Imperial College Healthcare NHS Trust, Oxfordbrookes University,
Abstract
Acceptability and effectiveness of digital prehabilitation and personalised support for cancer patients in the UK National Health Service.Org: Onkohealth, Imperial College, Imperial College Healthcare NHS Trust, Onkohealth Ltd,
Abstract
Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naïve patients with cancer: Updated safety data.Org: Imperial College, University of Sussex, University of Surrey, Imperial College NHS Trust, Imperial College Healthcare NHS Trust,
Abstract
Neoadjuvant immunotherapy with ipilimumab plus nivolumab and radiologically and pathologically quantifiable responses through modulation of the tumour microenvironment in resectable hepatocellular carcinoma.Org: Imperial College, Imperial College London, Imperial College, St Mary's Campus, Imperial College Healthcare NHS Trust, Barts and The London HPB Centre,
Abstract
The impact of cancer prehabilitation on psychological outcomes and quality of life in patients with gastro-oesophageal cancer.Org: Imperial College, London Regional Cancer Center, Imperial College Healthcare NHS Trust,
Abstract
Effect of a digital biopsychometric risk profile of patients with cancer on the delivery of risk-stratified personalised prehabilitation.Org: Imperial College, Imperial College Healthcare NHS Trust, Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barking, Havering and Redbridge NHS Trust, Onkohealth,
Abstract
BARRIERS TO SHARED DECISION-MAKING WITH WOMEN OF REPRODUCTIVE AGE AFFECTED BY CHRONIC INFLAMMATORY DISEASESOrg: AXDEV Group Inc., Imperial College Healthcare NHS Trust, Guy’s and St. Thomas’ Hospitals Trust, UCB Biopharma,